Literature DB >> 10806163

Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.

T A Seemungal1, G C Donaldson, A Bhowmik, D J Jeffries, J A Wedzicha.   

Abstract

Although exacerbations of chronic obstructive pulmonary disease (COPD) are associated with symptomatic and physiological deterioration, little is known of the time course and duration of these changes. We have studied symptoms and lung function changes associated with COPD exacerbations to determine factors affecting recovery from exacerbation. A cohort of 101 patients with moderate to severe COPD (mean FEV(1) 41.9% predicted) were studied over a period of 2.5 yr and regularly followed when stable and during 504 exacerbations. Patients recorded daily morning peak expiratory flow rate (PEFR) and changes in respiratory symptoms on diary cards. A subgroup of 34 patients also recorded daily spirometry. Exacerbations were defined by major symptoms (increased dyspnea, increased sputum purulence, increased sputum volume) and minor symptoms. Before onset of exacerbation there was deterioration in the symptoms of dyspnea, sore throat, cough, and symptoms of a common cold (all p < 0.05), but not lung function. Larger falls in PEFR were associated with symptoms of increased dyspnea (p = 0.014), colds (p = 0.047), or increased wheeze (p = 0.009) at exacerbation. Median recovery times were 6 (interquartile range [IQR] 1 to 14) d for PEFR and 7 (IQR 4 to 14) d for daily total symptom score. Recovery of PEFR to baseline values was complete in only 75.2% of exacerbations at 35 d, whereas in 7.1% of exacerbations at 91 d PEFR recovery had not occurred. In the 404 exacerbations where recovery of PEFR to baseline values was complete at 91 d, increased dyspnea and colds at onset of exacerbation were associated with prolonged recovery times (p < 0.001 in both cases). Symptom changes during exacerbation do not closely reflect those of lung function, but their increase may predict exacerbation, with dyspnea or colds characterizing the more severe. Recovery is incomplete in a significant proportion of COPD exacerbations.

Entities:  

Mesh:

Year:  2000        PMID: 10806163     DOI: 10.1164/ajrccm.161.5.9908022

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  309 in total

1.  Comparison of clinico-physiologic and CT imaging risk factors for COPD exacerbation.

Authors:  Jung-Wan Yoo; Yoonki Hong; Joon Beom Seo; Eun Jin Chae; Seung Won Ra; Ji-Hyun Lee; Eun Kyung Kim; Seunghee Baek; Tae-Hyung Kim; Woo Jin Kim; Jin Hwa Lee; Sang-Min Lee; Sangyeub Lee; Seong Yong Lim; Tae Rim Shin; Ho Il Yoon; Seung Soo Sheen; Jae Seung Lee; Jin Won Huh; Yeon-Mok Oh; Sang-Do Lee
Journal:  J Korean Med Sci       Date:  2011-11-29       Impact factor: 2.153

Review 2.  Management of an acute exacerbation of copd: are we ignoring the evidence?

Authors:  M K Johnson; R D Stevenson
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

3.  Exposing rodents to a combination of tobacco smoke and lipopolysaccharide results in an exaggerated inflammatory response in the lung.

Authors:  E L Hardaker; M S Freeman; N Dale; P Bahra; F Raza; K H Banner; C Poll
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

4.  Phenotypic and genetic heterogeneity among subjects with mild airflow obstruction in COPDGene.

Authors:  Jin Hwa Lee; Michael H Cho; Merry-Lynn N McDonald; Craig P Hersh; Peter J Castaldi; James D Crapo; Emily S Wan; Jennifer G Dy; Yale Chang; Elizabeth A Regan; Megan Hardin; Dawn L DeMeo; Edwin K Silverman
Journal:  Respir Med       Date:  2014-08-11       Impact factor: 3.415

5.  Detecting COPD exacerbations early using daily telemonitoring of symptoms and k-means clustering: a pilot study.

Authors:  Daniel Sanchez-Morillo; Miguel Angel Fernandez-Granero; Antonio León Jiménez
Journal:  Med Biol Eng Comput       Date:  2015-03-01       Impact factor: 2.602

6.  Increased Small Intestinal Permeability during Severe Acute Exacerbations of COPD.

Authors:  Roy T M Sprooten; Kaatje Lenaerts; Dionne C W Braeken; Ilvy Grimbergen; Erica P Rutten; Emiel F M Wouters; Gernot G U Rohde
Journal:  Respiration       Date:  2018-01-25       Impact factor: 3.580

7.  Management of exacerbations of COPD.

Authors:  Terence Seemungal; Jadwiga A Wedzicha
Journal:  Medicine (Abingdon)       Date:  2006-10-30

8.  Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; V N Maturu; Sahajal Dhooria; K T Prasad; Inderpaul S Sehgal; Lakshmikant B Yenge; Aditya Jindal; Navneet Singh; A G Ghoshal; G C Khilnani; J K Samaria; S N Gaur; D Behera
Journal:  Lung India       Date:  2013-07

Review 9.  Acute exacerbations in chronic obstructive pulmonary disease: current strategies with pharmacological therapy.

Authors:  Charles S Hall; Andreas Kyprianou; Alan M Fein
Journal:  Drugs       Date:  2003       Impact factor: 9.546

10.  Time course of recovery of health status following an infective exacerbation of chronic bronchitis.

Authors:  S Spencer; P W Jones
Journal:  Thorax       Date:  2003-07       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.